Authors: TROSCH RM FRIEDMAN JH LANNON MC PAHWA R SMITH D SEEBERGER LC OBRIEN CF LEWITT PA KOLLER WC

Citation: Rm. Trosch et al., CLOZAPINE USE IN PARKINSONS-DISEASE - A RETROSPECTIVE ANALYSIS OF A LARGE MULTICENTERED CLINICAL-EXPERIENCE, Movement disorders, 13(3), 1998, pp. 377-382

Authors: KURTH MC ADLER CH STHILAIRE M SINGER C WATERS C LEWITT P CHERNIK DA DORFLINGER EE YOO K LIEBERMAN AN BREWER M SAINTHILAIRE M PERY LM THOMAS C TURPIN L OBRIEN CF SEEBERGER LC DUNCAN KL CAVINESS JN DOUGLAS M WHEELER K RILEY D RAINEY P TANNER CM KELKER K LEWIS P TROSCH RM MISTURA KL MONTGOMERY EB LINDSEY B WEINER W SHULMAN LM SHELDON C WATERS CH WELSH M TRUGMAN JM LANDOW ER PEDDER SCJ SHIMON GS MAGNI G

Citation: Mc. Kurth et al., TOLCAPONE IMPROVES MOTOR FUNCTION AND REDUCES LEVODOPA REQUIREMENT INPATIENTS WITH PARKINSONS-DISEASE EXPERIENCING MOTOR FLUCTUATIONS - A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL, Neurology, 48(1), 1997, pp. 81-87

Authors: OBRIEN CF SEEBERGER LC SMITH DB

Citation: Cf. Obrien et al., SPASTICITY AFTER STROKE - EPIDEMIOLOGY AND OPTIMAL TREATMENT, Drugs & aging, 9(5), 1996, pp. 332-340